TABLE 2.
Levels of IL-6 in plasmaa
| Time (h) | IL-6
level (ng/ml) (mean ± SEM) in indicated treatment group
|
||
|---|---|---|---|
| Sham | 25G | 21G | |
| 2 | 5 ± 3 | 15 ± 5 | 30 ± 17 |
| 4 | 27 ± 6 | 364 ± 116 | 303 ± 125b |
| 8 | 6 ± 2.5 | 435 ± 150 | 1,390 ± 781b |
| 12 | 5 ± 1 | 117 ± 50 | 1,413 ± 932b |
| 16 | 19 ± 15 | 43 ± 21 | 251 ± 93b |
| 20 | 0.32 ± 0.1 | 47 ± 12 | 183 ± 128b |
| 24 | 0.1 ± 0.07 | 19 ± 6 | 196 ± 110b |
Levels were elevated in all mice that underwent CLP. Similar to the 18G-treated group, the 21G-treated group had substantial IL-6 elevations that were significantly higher than those of the sham treatment group after 4 h.
P < 0.05 for 21G versus sham treatment groups.